Furosemide Tablets, USP, 80 mg, 100 Tablets bottles, Rx only, Manufactured by: Leading Pharma, LLC, Fairfield, NJ 07004, NDC 69315-118-01
CGMP Deviations; presence of N-nitroso-Furosemide (NNF) above the recommended intake limit.
Quick Facts at a Glance
- Recall Date
- March 20, 2026
- Hazard Level
- HIGH
- Brands
- FUROSEMIDE, Leading Pharma, LLC
- Geographic Scope
- 1 states
Hazard Information
CGMP Deviations; presence of N-nitroso-Furosemide (NNF) above the recommended intake limit.
What You Should Do
Consumers and healthcare providers should stop using this product immediately. Contact Leading Pharma, LLC or your healthcare provider for guidance. Notification method: Letter
Get instant alerts for FUROSEMIDE recalls
Be the first to know. Free instant alerts to your inbox.
Full Description
Furosemide Tablets, USP, 80 mg, 100 Tablets bottles, Rx only, Manufactured by: Leading Pharma, LLC, Fairfield, NJ 07004, NDC 69315-118-01. Generic: FUROSEMIDE; Brand: FUROSEMIDE. Reason: CGMP Deviations; presence of N-nitroso-Furosemide (NNF) above the recommended intake limit.. Classification: Class II. Quantity: 9384 bottles. Distribution: US Nationwide.
Browse More Recalls
Safety Guide
Not sure what to do next? Our guide walks you through the process step by step.
Read: How to Get Refunds and ReplacementsWant to Know First?
Get instant alerts for recalls that affect you. Free forever.